Publications
Found 55 results
Filters: Author is De Baetselier, Patrick [Clear All Filters]
"MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis.",
PLoS Pathog, vol. 12, issue 9, pp. e1005862, 2016 Sep.
"The non-mammalian MIF superfamily.",
Immunobiology, 2016 Oct 12.
"Development of a pHrodo-based assay for the assessment of in vitro and in vivo erythrophagocytosis during experimental trypanosomosis.",
PLoS Negl Trop Dis, vol. 9, issue 3, pp. e0003561, 2015 Mar.
"Iron Homeostasis and Trypanosoma brucei Associated Immunopathogenicity Development: A Battle/Quest for Iron.",
Biomed Res Int, vol. 2015, pp. 819389, 2015.
"Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm.",
Immunobiology, vol. 220, issue 2, pp. 200-9, 2015 Feb.
"Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.",
J Nucl Med, vol. 55, issue 5, pp. 824-9, 2014 May.
"Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host.",
Science, vol. 337, issue 6093, pp. 463-6, 2012 Jul 27.
"Affinity is an important determinant of the anti-trypanosome activity of nanobodies.",
PLoS Negl Trop Dis, vol. 6, issue 11, pp. e1902, 2012.
"Tsetse salivary gland proteins 1 and 2 are high affinity nucleic acid binding proteins with residual nuclease activity.",
PLoS One, vol. 7, issue 10, pp. e47233, 2012.
"Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.",
Br J Pharmacol, vol. 165, issue 7, pp. 2341-53, 2012 Apr.
"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.",
PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
"The central role of macrophages in trypanosomiasis-associated anemia: rationale for therapeutical approaches.",
Endocr Metab Immune Disord Drug Targets, vol. 10, issue 1, pp. 71-82, 2010 Mar.
"In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.",
J Nucl Med, vol. 51, issue 7, pp. 1099-106, 2010 Jul.
"Nanobodies as tools for in vivo imaging of specific immune cell types.",
J Nucl Med, vol. 51, issue 5, pp. 782-9, 2010 May.
"A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.",
J Immunol, vol. 184, issue 10, pp. 5696-704, 2010 May 15.
"Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis.",
Microbes Infect, vol. 12, issue 5, pp. 389-99, 2010 May.
"Camelid immunoglobulins and nanobody technology.",
Vet Immunol Immunopathol, vol. 128, issue 1-3, pp. 178-83, 2009 Mar 15.
"Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.",
J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
"The role of B-cells and IgM antibodies in parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected mice.",
PLoS Pathog, vol. 4, issue 8, pp. e1000122, 2008.
"Role of iron homeostasis in trypanosomiasis-associated anemia.",
Immunobiology, vol. 213, issue 9-10, pp. 823-35, 2008.
"African trypanosomosis: from immune escape and immunopathology to immune intervention.",
Vet Parasitol, vol. 148, issue 1, pp. 3-13, 2007 Aug 19.
"Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response.",
J Infect Dis, vol. 195, issue 10, pp. 1513-20, 2007 May 15.
"A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology.",
J Immunol, vol. 179, issue 6, pp. 4003-14, 2007 Sep 15.
"Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing.",
J Infect Dis, vol. 196, issue 6, pp. 954-62, 2007 Sep 15.
"[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].",
Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.